Trinity Biotech (TRIB) FCF Margin Growth (1y) (2010 - 2024)
Trinity Biotech (TRIB) FCF Margin Growth (1y) (2010 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -80.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 473.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -192.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -431.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -1,716.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2,833.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 2,811.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -125.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Trinity Biotech | 93,750.00 | -5.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1,942.00 |
| Jun 30, 2024 | 2,658.00 |
| Mar 31, 2024 | 2.00 |
| Dec 31, 2023 | -1,339.00 |
| Sep 30, 2023 | -117.00 |
| Jun 30, 2023 | -5,129.00 |
| Dec 31, 2022 | -538.00 |
| Jun 30, 2022 | 0.00 |
| Jun 30, 2018 | -630.00 |
| Dec 31, 2016 | -53.00 |
| Dec 31, 2015 | 240.00 |
| Dec 31, 2014 | -203.00 |
| Dec 31, 2013 | 4.00 |
| Dec 31, 2012 | 151.00 |
| Dec 31, 2011 | 342.00 |
| Dec 31, 2010 | -458.00 |
| Sep 30, 2010 | 303.00 |
| Jun 30, 2010 | -93.00 |
| Mar 31, 2010 | -3.00 |